Reoperation of left heart valve bioprostheses according to age at implantation

Circulation

Volumn 124, Issue 11 SUPPL. 1, 2011, Pages

  Chan, Vincent ^a   Malas, Tarek ^a   Lapierre, Harry ^a   Boodhwani, Munir ^a   Lam, B Khanh ^a   Rubens, Fraser D ^a   Hendry, Paul J ^a   Masters, Roy G ^a   Goldstein, William ^a   Mesana, Thierry G ^a   Ruel, Marc ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

aortic valve; bioprosthesis; general; mitral valve; reoperation; surgery

Indexed keywords

ADULT; AGE; AGED; AORTA VALVE PROSTHESIS; AORTA VALVE REPLACEMENT; ARTICLE; CORONARY ARTERY BYPASS GRAFT; FEMALE; HEART VALVE BIOPROSTHESIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE PROSTHESIS; MITRAL VALVE REPLACEMENT; PRIORITY JOURNAL; PROGNOSIS; REOPERATION; STENT; SURGICAL RISK;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AORTIC VALVE; BIOPROSTHESIS; FOLLOW-UP STUDIES; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MIDDLE AGED; MITRAL VALVE; PROGNOSIS; REOPERATION; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 80052693187     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.110.011973     Document Type: Article

References (24)

1. Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS; 2006 Writing Committee Members; American College of Cardiology/American Heart Association Task Force. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2008;118:e523-e661.
2. Khan SS, Trento A, DeRobertis M, Kass RM, Sandhu M, Czer LS, Blanche C, Raissi S, Fontana GP, Cheng W, Chaux A, Matloff JM. Twenty-year comparison of tissue and mechanical valve replacement. J Thorac Cardiovasc Surg. 2001;122:257-269.
3. Chan V, Kulik A, Tran A, Hendry P, Masters R, Mesana TG, Ruel M. Long-term clinical and hemodynamic performance of the Hancock II versus the Perimount aortic bioprostheses. Circulation. 2010;122(11 suppl):S10-S16.
4. Ruel M, Chan V, Bédard P, Kulik A, Ressler L, Lam BK, Rubens FD, Goldstein W, Hendry PJ, Masters RG, Mesana TG. Very long-term survival implications of heart valve replacement with tissue versus mechanical prostheses in adults-60 years of age. Circulation. 2007; 116(11 suppl):I294-I300. (Pubitemid 47480804)
5. David TE, Armstrong S, Maganti M. Hancock II bioprosthesis for aortic valve replacement: the gold standard of bioprosthetic valves durability? Ann Thorac Surg. 2010;90:775-781.
6. Poirer NC, Pelletier LC, Pellerin M, Carrier M. 15-year experience with the Carpentier-Edwards pericardial bioprosthesis. Ann Thorac Surg. 1998;66(6 suppl):S57-S61. (Pubitemid 29087131)
7. Eichinger WB, Hettich IM, Ruzicka DJ, Holper K, Schricker C, Bleiziffer S, Lange R. Twenty-year experience with the St. Jude Medical Biocor bioprosthesis in the aortic position. Ann Thorac Surg. 2008;86: 1204-1211.
8. Jamieson WR, Burr LH, Miyagishima RT, Germann E, Macnab JS, Stanford E, Chan F, Janusz MT, Ling H. Carpentier-Edwards supraannular aortic porcine bioprosthesis: clinical performance over 20 years. J Thorac Cardiovasc Surg. 2005;130:994-1000. (Pubitemid 41427329)
9. Ruel M, Kulik A, Lam BK, Rubens FD, Hendry PJ, Masters RG, Bédard P, Mesana TG. Long-term outcomes of valve replacement with modern prostheses in young adults. Eur J Cardiothorac Surg. 2005;27:425-433. (Pubitemid 40312350)
10. Brown JM, O'Brien SM, Wu C, Sikora JA, Griffith BP, Gammie JS. Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. J Thorac Cardiovasc Surg. 2009;137:82-90.
11. Gammie JS, Sheng S, Griffith BP, Peterson ED, Rankin JS, O'Brien SM, Brown JM. Trends in mitral valve surgery in the United States: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database. Ann Thorac Surg. 2009;87:1431-1437.
12. Barnett SD, Ad N. Surgery for aortic and mitral valve disease in the United States: a trend of change in surgical practice between 1998 and2005. J Thorac Cardiovasc Surg. 2009;137:1422-1429.
13. Klieverik LM, Noorlander M, Takkenberg JJ, Kappetein AP, Bekkers JA, van Herwerden LA, Bogers AJ. Outcome after aortic valve replacement in young adults: is patient profile more important than prosthesis type? J Heart Valve Dis. 2006;15:479-487. (Pubitemid 44122675)
14. Rieß FC, Bader R, Cramer E, Hansen L, Schiffelers S, Wallrath J, Wahl G. The Mosaic porcine bioprosthesis: Role of age on clinical performance in aortic position. J Thorac Cardiovasc Surg. 2011;141:1440-1448.
15. Mykén PS, Bech-Hansen O. A 20-year experience of 1712 patients with the Biocor porcine bioprosthesis. J Thorac Cardiovasc Surg. 2009;137: 76-81.
16. Akins CW, Miller DC, Turina MI, Kouchoukos NT, Blackstone EH, Grunkemeier GL, Takkenberg JJ, David TE, Butchart EG, Adams DH, Shahian DM, Hagl S, Mayer JE, Lytle BW; Councils of the American Association for Thoracic Surgery; Society of Thoracic Surgeons; European Association for Cardio-Thoracic Surgery; Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity. Guidelines for reporting mortality and morbidity after cardiac valve interventions. J Thorac Cardiovasc Surg. 2008;135:732-738. (Pubitemid 351417944)
17. Schoenfeld D. Residuals for the proportional hazards regresssion model. Biometrika. 1982;69:239-241.
18. Chan V, Jamieson WR, Germann E, Chan F, Miyagishima RT, Burr LH, Janusz MT, Ling H, Fradet GJ. Performance of bioprostheses and mechanical prostheses assessed by composites of valve-related complications to 15 years after aortic valve replacement. J Thorac Cardiovasc Surg. 2006;131:1267-1273. (Pubitemid 43776088)
19. Jamieson WR, von Lipinski O, Miyagishima RT, Burr LH, Janusz MT, Ling H, Fradet GJ, Chan F, Germann E. Performance of bioprostheses and mechanical prostheses assessed by composites of valve-related complications to 15 years after mitral valve replacement. J Thorac Cardiovasc Surg. 2005;129:1301-1308. (Pubitemid 40804847)
20. Fine J, Gray R. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496-509.
21. Dagenais F, Cartier P, Voisine P, Desaulniers D, Perron J, Baillot R, Raymond G, Métras J, Doyle D, Mathieu P. Which biologic valve should we select for the 45-to 65-year-old age group requiring aortic valve replacement? J Thorac Cardiovasc Surg. 2005;129:1041-1049. (Pubitemid 40631424)
22. El-Hamamsy I, Clark L, Stevens LM, Sarang Z, Melina G, Takkenberg JJ, Yacoub MH. Late outcomes following freestyle versus homograft aortic root replacement: results from a prospective randomized trial. J Am Coll Cardiol. 2010;55:368-376.
23. Cohen G, Zagorski B, Christakis GT, Joyner CD, Vincent J, Sever J, Harbi S, Feder-Elituv R, Moussa F, Goldman BS, Fremes SE. Are stentless valves hemodynamically superior to stented valves? Long-term follow-up of a randomized trial comparing Carpentier-Edwards pericardial valve with the Toronto Stentless Porcine Valve. J Thorac Cardiovasc Surg. 2010;139:848-859.
24. Masters RG, Walley VM, Pipe AL, Keon WJ. Long-term experience with the Ionescu-Shiley pericardial valve. Ann Thorac Surg. 1995;60(2 suppl): S288-S291.